ReviewPharmaceuticals (Basel, Switzerland)2025

Risk of Hearing Loss in Patients Treated with Exendin-4 Derivatives: A Network Meta-Analysis of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors.

Jiann-Jy Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.